Bupropion Hydrochloride

Records for this ingredient, by country (identity only).

ATC N06AX12 · 4 markets · 10 records

Bupropion Hydrochloride 4 markets · 10 records Forms

Filters

MarketHK 6 AU 2 SG 1 FR 1

Kind

Strength

HK 6 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

6 records · 0 manufacturers 6 registros · 0 fabricantes 6 个记录 · 0 个厂家 6 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名BUPROPION HYDROCHLORIDE SUSTAINED-RELEASE TABLETS 150MG ×1CONTRAVE PROLONGED RELEASE TABLET 8MG/90MG ×2NEUROTRAX SUSTAINED-RELEASE TABLETS 150MG ×1PMS-BUPROPION ×3WELLBUTRIN XL EXTENDED RELEASE TAB 300 MG ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

AU 2 records · 2 shown of 2 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

Only this ingredient

150 mgtablet · extended-releaseZYBAN SR bupropion hydrochloride 150mg tablet blister pack also in FR unknown

Combination products containing this ingredient

90 mgtablet · extended-release CombinationBupropion Hydrochloride 90 mg + Naltrexone Hydrochloride 8 mgCONTRAVE 8/90 naltrexone hydrochloride 8 mg and bupropion hydrochloride 90 mg modified-release tablet blister pack also in SG unknown

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Combination products containing this ingredient

90 mgtablet · extended-release CombinationBupropion Hydrochloride 90 mg + Naltrexone Hydrochloride 8 mgCONTRAVE PROLONGED RELEASE TABLET 8MG/90MG also in AU

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

150 mgtablet · extended-releaseZYBAN L.P. 150 mg, comprimé à libération prolongée also in AU

Side-by-side table

Strength / form / release	AU	SG	HK	FR
150 mg tablet · extended-release	ZYBAN SR bupropion hydrochloride 150mg tablet blister pack	not recorded	not recorded	ZYBAN L.P. 150 mg, comprimé à libération prolongée
90 mg Combination Bupropion Hydrochloride 90 mg + Naltrexone Hydrochloride 8 mg tablet · extended-release	CONTRAVE 8/90 naltrexone hydrochloride 8 mg and bupropion hydrochloride 90 mg modified-release tablet blister pack	CONTRAVE PROLONGED RELEASE TABLET 8MG/90MG	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	BUPROPION HYDROCHLORIDE SUSTAINED-RELEASE TABLETS 150MG NEUROTRAX SUSTAINED-RELEASE TABLETS 150MG PMS-BUPROPION +1 WELLBUTRIN XL EXTENDED RELEASE TAB 300 MG	not recorded
not disclosed Combination Bupropion Hydrochloride + Naltrexone Hydrochloride unknown	not recorded	not recorded	CONTRAVE PROLONGED RELEASE TABLET 8MG/90MG	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.